PHST-001

N/A

Report date: 2026/04/23 20:00:25

Base Information

Drug NamePHST-001
Drug Alias NamePHST-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Signal transducer CD24
TargetsSignal transducer CD24
Therapy Area/IndicationsSolid tumoursEndometrial NeoplasmsCentral Nervous System Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPheast Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPheast Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursEndometrial NeoplasmsCentral Nervous System Neoplasms +[5] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A